Cardiome Pharma Corporation (CORV)
(Delayed Data from NSDQ)
$2.66 USD
+0.06 (2.31%)
Updated May 3, 2019 03:59 PM ET
After-Market: $2.66 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[CORV]
Reports for Purchase
Showing records 1 - 20 ( 54 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
ADVANZ to Acquire Correvio for $76M; Adjusting PT to $0.42; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Brinavess AdCom Delivers a Blow; Downgrade to Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
FDA Advisory Panel Recommends Against Brinavess Approval, And We Assume That FDA Will Concur - Shifting To HOLD
Provider: Echelon Welath Partners
Analyst: LOE D
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
All Eyes on Brinavess AdCom and PDUFA Date in December; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Industry: Medical - Drugs
Soft Revenue In FQ319 Should Lead Into Strong FQ419. Brinavess/IV Vernakalant FDA Review On The Horizon
Provider: Echelon Welath Partners
Analyst: LOE D